Catalent Inc. (CTLT) News
Filter CTLT News Items
CTLT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CTLT News Highlights
- For CTLT, its 30 day story count is now at 4.
- Over the past 4 days, the trend for CTLT's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
Latest CTLT News From Around the Web
Below are the latest news stories about CATALENT INC that investors may wish to consider to help them evaluate CTLT as an investment opportunity.
Catalent Announces Closing of Incremental Term LoansSOMERSET, N.J., December 19, 2023--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that its wholly owned subsidiary, Catalent Pharma Solutions, Inc., as borrower, and certain other wholly owned subsidiaries of Catalent, entered into an amendment, dated as of December 19, 2023, to its existing credit agreement for the issuance of new incremental term loans in an aggregate amount of $600 million, which was |
Catalent (CTLT) Up 4.1% Since Last Earnings Report: Can It Continue?Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Here's Why You Should Retain Catalent (CTLT) Stock for NowCatalent's (CTLT) products and services portfolio and technology foundation raise optimism about the stock. |
Catalent Regains Compliance with NYSE Continued Listing StandardsSOMERSET, N.J., December 15, 2023--Catalent, Inc. ("Catalent" or the "Company") (NYSE: CTLT) announced today that the Company has received written notification ("Notice") from the New York Stock Exchange ("NYSE") that it has officially regained compliance with the NYSE continued listing standards. |
Why Analysts Are Bullish on Intel and Target Stock, Cautious on Advance Auto PartsRESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s. |
Catalent (CTLT) Reports Q1 Earnings: What Key Metrics Have to SayThe headline numbers for Catalent (CTLT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
Catalent, Inc. (NYSE:CTLT) Q1 2024 Earnings Call TranscriptCatalent, Inc. (NYSE:CTLT) Q1 2024 Earnings Call Transcript November 15, 2023 Catalent, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.13. Operator: Hello all, and welcome to Catalent’s First Quarter Fiscal Year 2024 Earnings Call. My name is Lydia and I’ll be your operator today. [Operator Instructions]. I’ll now hand you over to […] |
Catalent (CTLT) Preliminary Q1 Revenues Dampened by Lower SalesCatalent (CTLT) records lower revenues in Biologics segments in its first-quarter fiscal 2024, resulting in overall soft preliminary performance. |
Midday movers: Walmart, Macy's, Alibaba, Cisco and moreInvesting.com -- U.S. stocks were falling as the steam ran out of their recent rally after Walmart's cautious outlook on consumer spending. |
Stock Market News for Nov 16, 2023Wall Street closed higher on Wednesday after a sharp rally in the previous day. |